Status:
COMPLETED
Antibody Production Following H1N1 Influenza Vaccination in Organ Transplant Patients
Lead Sponsor:
Sahlgrenska University Hospital
Conditions:
Organ Transplantation
Eligibility:
All Genders
18+ years
Brief Summary
Organ transplant patients and staff members at the Transplant Institute have received pandemic H1N1 influenza vaccine (Pandemrix) and specific antibody production was measured by haemagglutination inh...
Detailed Description
A total of 100 organ transplant patients and 36 healthy controls were included in the study. All individuals were vaccinated between October and November 2009 and received 2 doses of Pandemrix. Serum ...
Eligibility Criteria
Inclusion
- Cohort number 1:Organ transplant patients who were vaccinated and serum sample drawn at baseline.
- Cohort number 2: Staff members who were vaccinated and serum sample drawn at baseline.
Exclusion
- Cohort number 1: Organ transplant patients who were vaccinated and no serum sample drawn at baseline.
- Cohort number 2: Staff members who were vaccinated and no serum sample drawn at baseline.
Key Trial Info
Start Date :
October 1 2009
Trial Type :
OBSERVATIONAL
End Date :
August 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01254955
Start Date
October 1 2009
End Date
August 1 2011
Last Update
January 16 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Transplant Institute, Sahlgrenska University Hospital
Gothenburg, Västra Götaland County, Sweden, 413 45